Pierre-Fréderic Keller
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
Sudano I, Mach F, Moccetti T, Burkard T, Fahe C, Delabays A, Rickli H, Keller P, Dopheide J, Bodenmann S, Fiolka T, Ehret G, Spirk D. Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE). Front Cardiovasc Med 2022; 9:953040.
Jul 15, 2022Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
Jul 15, 2022Front Cardiovasc Med 2022; 9:953040
Sudano Isabella, Mach François, Moccetti Tiziano, Burkard Thilo, Fahe Christian, Delabays Alain, Rickli Hans, Keller Pierre-Fréderic, Dopheide Jörn, Bodenmann Sereina, Fiolka Tom, Ehret Georg, Spirk David
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
Carballo D, Calmy A, Ledergerber B, Keller P, Erne P, Fehr J, Cusini A, Schmid P, Fasel D, Bernasconi E, Clerc O, Hirschel B, Radovanovic D, Bähler C, Carballo S, Delhumeau C, Swiss HIV Cohort Study and AMIS registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther 2015; 12:4.
Feb 22, 2015Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
Feb 22, 2015AIDS Res Ther 2015; 12:4
Carballo David, Calmy Alexandra, Ledergerber Bruno, Keller Pierre-Fréderic, Erne Paul, Fehr Jan, Cusini Alexia, Schmid Patrick, Fasel Dominique, Bernasconi Enos, Clerc Olivier, Hirschel Bernard, Radovanovic Dragona, Bähler Caroline, Carballo Sebastian, Delhumeau Cécile, Swiss HIV Cohort Study and AMIS registry